SMAP
SportsMap Tech Acquisition Corp.
Shell Companies
Market Cap$5.30B
5Y Perf.+166.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SMAP vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
GENI
Genius Sports Limited
Internet Content & Information
Market Cap$1.08B
5Y Perf.-53.7%
SMAP vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SMAP | GENI |
|---|---|---|
| Industry | Shell Companies | Internet Content & Information |
| Market Cap | $5.30B | $1.08B |
| Revenue (TTM) | $7M | $713M |
| Net Income (TTM) | $-12M | $-159M |
| Gross Margin | 100.0% | 22.6% |
| Operating Margin | -189.5% | -18.3% |
| Forward P/E | — | 161.2x |
| Total Debt | $0.00 | $30M |
| Cash & Equiv. | $4M | $281M |
SMAP vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SMAP
GENI
| Stock | Nov 21 | May 26 | Return |
|---|---|---|---|
| SportsMap Tech Acqu… (SMAP) | 100 | 266.1 | +166.1% |
| Genius Sports Limit… (GENI) | 100 | 46.3 | -53.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SMAP vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: SMAP leads in 3 of 6 categories, making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Genius Sports Limited is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
SMAP
SportsMap Tech Acquisition Corp.
The Banking Pick
SMAP carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 0.90
- Rev growth 36.3%, EPS growth 82.7%
- 168.5% 10Y total return vs GENI's -56.0%
Best for: income & stability and growth exposure
GENI
Genius Sports Limited
The Quality Compounder
GENI is the clearest fit if your priority is quality and efficiency.
- -22.3% margin vs SMAP's -290.4%
- -15.4% ROA vs SMAP's -104.6%, ROIC -16.6% vs -114.7%
Best for: quality and efficiency
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | SMAP | 36.3% NII/revenue growth vs GENI's 31.0% |
| Quality / Margins | GENI | -22.3% margin vs SMAP's -290.4% |
| Stability / Safety | SMAP | Beta 0.90 vs GENI's 1.39 |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | SMAP | +13.4% vs GENI's -56.9% |
| Efficiency (ROA) | GENI | -15.4% ROA vs SMAP's -104.6%, ROIC -16.6% vs -114.7% |
SMAP vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
SMAP vs GENI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLGENILAGGINGSMAP
SMAPSportsMap Tech Acquis…
2leads
GENIGenius Sports Limited
3leads
6 Total Categories
CATEGORYLEADERvs SMAPMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
GENI3/5
Valuation MetricsMultiples, price ratios, and targets
GENI2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
GENI6/8
Total Returns1Y, 3Y, 5Y total returns with dividends
SMAP6/6
Risk & VolatilityBeta, volatility, and downside exposure
SMAP2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
GENI leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
GENI is the larger business by revenue, generating $713M annually — 96.4x SMAP's $7M. Profitability is closely matched — net margins range from -22.3% (GENI) to -2.9% (SMAP).
| Metric | SMAPSportsMap Tech Ac… | GENIGenius Sports Lim… |
|---|---|---|
| RevenueTrailing 12 months | $7M | $713M |
| EBITDAEarnings before interest/tax | $36M | -$54M |
| Net IncomeAfter-tax profit | -$12M | -$159M |
| Free Cash FlowCash after capex | -$13M | $16M |
| Gross MarginGross profit ÷ Revenue | +100.0% | +22.6% |
| Operating MarginEBIT ÷ Revenue | -189.5% | -18.3% |
| Net MarginNet income ÷ Revenue | -2.9% | -22.3% |
| FCF MarginFCF ÷ Revenue | -2.5% | +2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +30.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +85.3% | -6.0% |
GENI leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
GENI leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | SMAPSportsMap Tech Ac… | GENIGenius Sports Lim… |
|---|---|---|
| Market CapShares × price | $5.3B | $1.1B |
| Enterprise ValueMkt cap + debt − cash | $5.3B | $834M |
| Trailing P/EPrice ÷ TTM EPS | -239.50x | -10.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 161.17x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 716.09x | 1.62x |
| Price / BookPrice ÷ Book value/share | 431.36x | 1.55x |
| Price / FCFMarket cap ÷ FCF | — | 16.79x |
GENI leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
GENI leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
GENI delivers a -22.2% return on equity — every $100 of shareholder capital generates $-22 in annual profit, vs $-150 for SMAP. On the Piotroski fundamental quality scale (0–9), SMAP scores 4/9 vs GENI's 3/9, reflecting mixed financial health.
| Metric | SMAPSportsMap Tech Ac… | GENIGenius Sports Lim… |
|---|---|---|
| ROE (TTM)Return on equity | -150.0% | -22.2% |
| ROA (TTM)Return on assets | -104.6% | -15.4% |
| ROICReturn on invested capital | -114.7% | -16.6% |
| ROCEReturn on capital employed | -155.2% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | — | 0.04x |
| Net DebtTotal debt minus cash | -$4M | -$250M |
| Cash & Equiv.Liquid assets | $4M | $281M |
| Total DebtShort + long-term debt | $0 | $30M |
| Interest CoverageEBIT ÷ Interest expense | -336.84x | -75.96x |
GENI leads this category, winning 6 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
SMAP leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SMAP five years ago would be worth $26,848 today (with dividends reinvested), compared to $2,354 for GENI. Over the past 12 months, SMAP leads with a +13.4% total return vs GENI's -56.9%. The 3-year compound annual growth rate (CAGR) favors SMAP at 36.4% vs GENI's 2.7% — a key indicator of consistent wealth creation.
| Metric | SMAPSportsMap Tech Ac… | GENIGenius Sports Lim… |
|---|---|---|
| YTD ReturnYear-to-date | +5.9% | -59.2% |
| 1-Year ReturnPast 12 months | +13.4% | -56.9% |
| 3-Year ReturnCumulative with dividends | +153.6% | +8.4% |
| 5-Year ReturnCumulative with dividends | +168.5% | -76.5% |
| 10-Year ReturnCumulative with dividends | +168.5% | -56.0% |
| CAGR (3Y)Annualised 3-year return | +36.4% | +2.7% |
SMAP leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
SMAP leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SMAP is the less volatile stock with a 0.90 beta — it tends to amplify market swings less than GENI's 1.39 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SMAP currently trades 99.1% from its 52-week high vs GENI's 32.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | SMAPSportsMap Tech Ac… | GENIGenius Sports Lim… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.90x | 1.39x |
| 52-Week HighHighest price in past year | $26.60 | $13.73 |
| 52-Week LowLowest price in past year | $23.34 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +32.0% |
| RSI (14)Momentum oscillator 0–100 | 62.4 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 547 | 5.6M |
SMAP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | SMAPSportsMap Tech Ac… | GENIGenius Sports Lim… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $11.17 |
| # AnalystsCovering analysts | — | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Insufficient data to determine a leader in this category.
Key Takeaway
GENI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). SMAP leads in 2 (Total Returns, Risk & Volatility).
Best OverallGenius Sports Limited (GENI)Leads 3 of 6 categories
Loading custom metrics...
SMAP vs GENI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is SMAP or GENI a better buy right now?
For growth investors, SportsMap Tech Acquisition Corp.
(SMAP) is the stronger pick with 36. 3% revenue growth year-over-year, versus 31. 0% for Genius Sports Limited (GENI). Analysts rate Genius Sports Limited (GENI) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — SMAP or GENI?
Over the past 5 years, SportsMap Tech Acquisition Corp.
(SMAP) delivered a total return of +168. 5%, compared to -76. 5% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: SMAP returned +168. 5% versus GENI's -56. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — SMAP or GENI?
By beta (market sensitivity over 5 years), SportsMap Tech Acquisition Corp.
(SMAP) is the lower-risk stock at 0. 90β versus Genius Sports Limited's 1. 39β — meaning GENI is approximately 55% more volatile than SMAP relative to the S&P 500.
04Which is growing faster — SMAP or GENI?
By revenue growth (latest reported year), SportsMap Tech Acquisition Corp.
(SMAP) is pulling ahead at 36. 3% versus 31. 0% for Genius Sports Limited (GENI). Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — SMAP or GENI?
Genius Sports Limited (GENI) is the more profitable company, earning -16.
7% net margin versus -290. 4% for SportsMap Tech Acquisition Corp. — meaning it keeps -16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GENI leads at -15. 6% versus -189. 5% for SMAP. At the gross margin level — before operating expenses — SMAP leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — SMAP or GENI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is SMAP or GENI better for a retirement portfolio?
For long-horizon retirement investors, SportsMap Tech Acquisition Corp.
(SMAP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 90), +168. 5% 10Y return). Both have compounded well over 10 years (SMAP: +168. 5%, GENI: -56. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between SMAP and GENI?
These companies operate in different sectors (SMAP (Financial Services) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 15%
- Gross Margin > 13%
Revenue Growth>
%
(SMAP: 36.3% · GENI: 30.5%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.